MedTech Acquisition Corporation Stock Price, News & Analysis
Company Description
MedTech Acquisition Corporation (NASDAQ: MTAC) is a publicly traded shell companies company in the Financial Services sector. The company has a market capitalization of $83.9M.
MTAC stock has declined 100.0% over the past year.
This page provides a comprehensive overview of MTAC stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
MedTech Acquisition Corporation (MTAC) stock. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $83.9M, MTAC is classified as a micro-cap stock with approximately 7.4M shares outstanding.
Latest News
MedTech Acquisition Corporation has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 5 with negative movement. Key topics include acquisition, management, clinical trial. View all MTAC news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
MTAC Company Profile & Sector Positioning
MedTech Acquisition Corporation (MTAC) operates in the Shell Companies industry within the broader Financial Services sector and is listed on the NASDAQ.
Investors comparing MTAC often look at related companies in the same sector, including Aequi Acquisitio (ARBG), Columbus Acquisition Corp (COLAU), Columbus Acquisition Corp (COLA), Cayson Acquisition Corp (CAPN), and YHN Acquisition I Ltd (YHNA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MTAC's relative position within its industry.